Cargando…

MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Xu, Qiuran, Zhang, Meiqi, Tu, Jianfeng, Pang, Linxiao, Cai, Wenwei, Liu, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129967/ https://www.ncbi.nlm.nih.gov/pubmed/33982780 http://dx.doi.org/10.3892/or.2021.8073

Ejemplares similares

[Retracted] MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2023)

HSP90 inhibits apoptosis and promotes growth by regulating HIF-1α abundance in hepatocellular carcinoma
por: Liu, Xin, et al.
Publicado: (2022)

microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma
por: Liu, Xin, et al.
Publicado: (2017)

MicroRNA-122 ameliorates corneal allograft rejection through the downregulation of its target CPEB1
por: Wang, Ting, et al.
Publicado: (2017)

MicroRNA-122 regulates docetaxel resistance of prostate cancer cells by regulating PKM2
por: Zhu, Zhirong, et al.
Publicado: (2020)

Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis
por: Wang, Zihao, et al.
Publicado: (2021)

[Corrigendum] MicroRNA‑92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7
por: Yang, Wei, et al.
Publicado: (2023)

HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2017)

PKM2 regulates Gli1 expression in hepatocellular carcinoma
por: XU, QIURAN, et al.
Publicado: (2014)

EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2
por: Chen, Shengnan, et al.
Publicado: (2020)

Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
por: Chun, Kwang-Hoon
Publicado: (2022)

Corrigendum to “Expression of miRNA-122 Induced by Liver Toxicants in Zebrafish”
por: Nam, Hyun-Sik, et al.
Publicado: (2017)

microRNA-34a overexpression inhibits cell migration and invasion via regulating SIRT1 in hepatocellular carcinoma
por: Zhou, Jianhui, et al.
Publicado: (2019)

Altered expression of microRNA-98 in IL-1β-induced cartilage degradation and its role in chondrocyte apoptosis
por: Wang, Jing, et al.
Publicado: (2018)

Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma
por: Luo, Jie, et al.
Publicado: (2013)

Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis
por: Zhao, Xiao-Fei, et al.
Publicado: (2020)

MicroRNA-122 regulates caspase-8 and promotes the apoptosis of mouse cardiomyocytes
por: Zhang, Z.W., et al.
Publicado: (2017)

Transcriptome dynamics of the microRNA inhibition response
por: Wen, Jiayu, et al.
Publicado: (2016)

Corrigendum to “Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats”
por: Silveira, André C., et al.
Publicado: (2018)

Cyclophilin D modulates cell death transition from early apoptosis to programmed necrosis induced by honokiol
por: Tian, Wei, et al.
Publicado: (2021)

Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC)
por: Shehab-Eldeen, Somaia, et al.
Publicado: (2019)

Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Corrigendum to “An Integrated Systems Biology Approach Identifies the Proteasome as A Critical Host Machinery for ZIKV and DENV Replication” [Genomics Proteomics Bioinformatics19 (1) (2021) 108–122]
por: Song, Guang, et al.
Publicado: (2022)

The functional significance of microRNA-145 in prostate cancer
por: Zaman, M S, et al.
Publicado: (2011)

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
por: Burchard, Julja, et al.
Publicado: (2010)

Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression
por: Taniguchi, Kohei, et al.
Publicado: (2018)

A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles
por: Guo, Jing, et al.
Publicado: (2021)

Expression of microRNA-122 contributes to apoptosis in H9C2 myocytes
por: Huang, Xiaoyan, et al.
Publicado: (2012)

Human peripheral blood-derived exosomes for microRNA delivery
por: Kang, Ji-Young, et al.
Publicado: (2019)

Corrigendum to “Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis”
por: Zhang, Hui, et al.
Publicado: (2017)

The Predictive Efficacy of Serum Exosomal microRNA-122 and microRNA-148a for Hepatocellular Carcinoma Based on Smart Healthcare
por: Deng, Peng, et al.
Publicado: (2022)

MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma
por: Hassan, Marwa, et al.
Publicado: (2022)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

MirGeneDB 2.0: the metazoan microRNA complement
por: Fromm, Bastian, et al.
Publicado: (2020)

Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells
por: He, Jialin, et al.
Publicado: (2015)

Bioinformatics analysis of gene expression alterations in microRNA-122 knockout mice with hepatocellular carcinoma
por: He, Bosheng, et al.
Publicado: (2017)

miR-122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3
por: Nie, Wenyuan, et al.
Publicado: (2019)

Corrigendum to “MicroRNA-30-5p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21”
por: Zhou, Zhenyu, et al.
Publicado: (2021)

Liver-specific microRNA-122: Biogenesis and function
por: Jopling, Catherine
Publicado: (2012)

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
por: Iorio, Marilena V, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9tdtr1q738lgkkarv8707sgi5d